Cart
sales@molnova.com
ARRY380
CAS No. 937265-83-3
ARRY380( ARRY-380 analog | ONT380 analog | ONT 380 analog | ONT-380 analog )
Catalog No. M16714 CAS No. 937265-83-3
ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 63 | In Stock |
|
| 5MG | 105 | In Stock |
|
| 10MG | 168 | In Stock |
|
| 25MG | 284 | In Stock |
|
| 50MG | 422 | In Stock |
|
| 100MG | 618 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARRY380
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
-
DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.
-
In Vitro——
-
In Vivo——
-
SynonymsARRY-380 analog | ONT380 analog | ONT 380 analog | ONT-380 analog
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR| HER2| p95-HER2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number937265-83-3
-
Formula Weight569.63
-
Molecular FormulaC29H27N7O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: > 10mM
-
SMILESCC1=C(OC2=CC3=NC=NN3C=C2)C=CC(NC2=NC=NC3=C2C=C(C=C3)C2=CC=C(CNCCS(C)(=O)=O)O2)=C1
-
Chemical Name6-[5-[[[2-(Methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Madala SK, et al. Am J Respir Cell Mol Biol. 2012 Mar;46(3):380-8.
molnova catalog
related products
-
EGFR-IN-7
EGFR-IN-7 is a selective and potent EGFR kinase inhibitor.TQB3804 displayed potent enzymatic activities for EGFRd746-750/T790M/C797S, EGFRL858R/T790M/C797S, EGFRd746-750/T790M, and EGFRL858R/T790M with IC50 of 0.46, 0.13, 0.26, and 0.19 nM respectively, and has similar enzymatic activity for EGFRWT (IC50 = 1.07) to Osimertinib.
-
PF-06747775
A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively.
-
BPR1J-097
BPR1J-097 is a novel FLT-3 inhibitor(IC50: 11±7 nM) with promising in vivo anti-tumor activities. It also inhibits FLT-3 D835Y (IC50: 3 nM).
